高敏C反应蛋白和高血压病性心功能不全的关系被引量：1

下载PDF

导出

摘要目的:探讨高敏C-反应蛋白(hs-CRP)在高血压心脏病性心功能不全中的变化及作用。方法:102例高血压患者被分为心功能不全组(舒张功能不全和收缩功能不全44例)和对照组(无心功能不全58例),比较两组间hs-CRP变化情况。结果:高血压心功能不全的hs-CRP含量较单纯高血压组有显著升高(P<0.01),并且收缩功能不全较舒张功能者明显升高(P<0.01)。hs-CRP变化与高血压心功能不全程度有关系,hs-CRP在心功能不全Ⅲ级组显著高于Ⅱ级组(P<0.05),Ⅳ级组显著高于Ⅲ级组(P<0.05)。结论:高血压心功能不全患者hs-CRP水平升高与心功能不全程度关系密切。hs-CRP可作为高血压心功能不全评价的重要参考指标。

作者何卫军何战斌

机构地区河南开封市中医药学校开封市第一人民医院

出处《中国社区医师（医学专业）》 2012年第10期266-267,共2页

关键词高敏C反应蛋白质高血压心功能不全

分类号 R541 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1Suff redini,Rupprecht HJ,Blankenbegs. The cardiovascular response of normal humans to the administration of endotoxin[J].New England Journal of Medicine,1989.280-287.
2聂海,祝之明,闫振成,倪银星,赵志钢,张刚,杨华.高敏C反应蛋白与代谢综合征组分及靶器官损害的关系[J].中华心血管病杂志,2004,32(12):1113-1117. 被引量：62
3牛振霞,张瑞岩.血清C反应蛋白和肌钙蛋白与严重心功能不全患者住院期预后的关系[J].介入放射学杂志,2004,13(S2):178-179. 被引量：3
4Torre-Amione G,Torre AG,Lamendola C. Expression and functional significance of tumor necrosis fact or receptors in human myocardium[J].Circulation,1995.1487-1493.
5Fich tl sch erer S,Rosenb erer G,Dirk H. Elevated C-reactive protein levels an d impaired endothelial vasoreactivity in patients with coronary artery disease[J].Circulation,2000.1000-1006.
6Hayaishr OR,Yamasaki Y,Katakami N. Elevated C reactive protein associates with early-stage carotid atherosclerosis in young subject s with type 1 diabetes[J].Diabetes Care,2002.1432-1438.
7Agrawal A. CRP after 2004[J].Mol Immuno,2005,(08):927-930.

二级参考文献28

1Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol, 2003, 149: 601-608.
2Pradhan AD, Cook NR, Buring JE, et al. C-reactive protein is independently associated with fasting insulin in nondiabetic women.Arterioscler Thromb Vasc Biol, 2003, 23: 650-655.
3Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 2002, 51: 1596-1600.
4Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002, 347: 1557-1565.
5Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA,2001, 285: 2486-2497.
6Stuveling EM, Bakker SJ, Hillege HL, et al. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension, 2004, 43:791-796.
7Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 2003, 107: 398-404.
8Devereux RB, Alonso DR, Lutas EM, et al.Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol, 1986, 57: 450-458.
9Tan CE, Chew SK, Ma S, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004, 27:1182-1186.
10Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003,107: 363-369.